Showing 291-300 of 333 grants

Title Institution Researcher Program Duration Total Award Amount
Optimization of fast-acting venom insulins as therapeutic candidates for T1D University of Utah Helena Safavi Improving Lives 01-September-2022 to 31-August-2025 $890,372.53
Metabolic modulation of Tregs for improved immunotherapy in T1D University of Utah Maria Bettini Cures 01-June-2024 to 31-May-2025 $187,487.77
Randomized trial of semaglutide for diabetic kidney disease in type 1 diabetes University of Washington Ian De Boer Improving Lives 01-September-2023 to 31-August-2026 $2,107,411.00
Effects of SGLT2 inhibition on early diabetic kidney disease: interrogation of renal energetics by functional imaging and single-cell transcriptomics University of Washington Petter Bjornstad Improving Lives 01-June-2024 to 30-November-2025 $488,511.63
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) University of Washington Petter Bjornstad Improving Lives 01-September-2025 to 31-August-2028 $2,040,014.30
A Multi-task Learning Framework for Developing Genetic Risk Score (GRS) Models of T1D for Multi-Ethnic Population University of Washington Shuai Huang Cures 01-August-2022 to 31-August-2025 $300,081.37
Promoting functional maturation of SC-derived beta-cells by novel Epigenetic regulators University of Washington Vincenzino Cirulli Cures 01-October-2024 to 30-September-2026 $500,000.00
microRNAs as regulators of stem cell differentiation into islet cells University of Washington Vincenzino Cirulli Cures 01-August-2025 to 31-July-2027 $600,000.00
Identifying the temporal functions of beta cell UPR in T1D University of Wisconsin-Madison (Board of Regents University of Wisconsin System) Feyza Engin Cures 01-February-2023 to 31-January-2026 $750,000.00
Single nucleus multiomics temporal profiling of islet immune cells in male and female NOD mice during UPR-deficiency-induced senescence University of Wisconsin-Madison (Board of Regents University of Wisconsin System) Feyza Engin Cures 01-February-2025 to 31-January-2028 $750,000.00